文献
J-GLOBAL ID:201902268788765225
整理番号:19A1582502
定量的腫瘍次元としてのPAM50遺伝子発現の再解釈は臨床試験の有用性を示す:乳癌におけるパクリタキセルに対する予後と反応への応用【JST・京大機械翻訳】
Re-interpretation of PAM50 gene expression as quantitative tumor dimensions shows utility for clinical trials: application to prognosis and response to paclitaxel in breast cancer
著者 (12件):
Camp Nicola J.
(Huntsman Cancer Institute, University of Utah, Salt Lake City, USA)
,
Camp Nicola J.
(Department of Internal Medicine, University of Utah, Salt Lake City, USA)
,
Madsen Michael J.
(Huntsman Cancer Institute, University of Utah, Salt Lake City, USA)
,
Herranz Jesus
(Spanish Breast Cancer Group, GEICAM, Madrid, Spain)
,
Rodriguez-Lescure Alvaro
(Spanish Breast Cancer Group, GEICAM, Madrid, Spain)
,
Rodriguez-Lescure Alvaro
(Hospital Universitario de Elche, Elche, Spain)
,
Ruiz Amparo
(Instituto Valenciano de Oncologia, Valencia, Spain)
,
Martin Miguel
(Spanish Breast Cancer Group, GEICAM, Madrid, Spain)
,
Martin Miguel
(Instituto de Investigacion Sanitaria Gregorio Maranon, Universidad Complutense, Madrid, Spain)
,
Martin Miguel
(Centro de Investigacion Biomedica en Red de Oncologia, CIBERONC-ISCIII, Madrid, Spain)
,
Bernard Philip S.
(Huntsman Cancer Institute, University of Utah, Salt Lake City, USA)
,
Bernard Philip S.
(Department of Pathology, University of Utah, Salt Lake City, USA)
資料名:
Breast Cancer Research and Treatment
(Breast Cancer Research and Treatment)
巻:
175
号:
1
ページ:
129-139
発行年:
2019年
JST資料番号:
W4122A
ISSN:
1573-7217
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)